Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial

Authors: Wai Tong Chien, Jolene Mui, Richard Gray, Eric Cheung

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

Current practice guidelines for schizophrenia care recommend that antipsychotic medication is essential for patients’ long-term maintenance treatment but their non-adherence to this medication is still a main obstacle to relapse prevention. This study evaluated the effects of a motivational-interviewing-based adherence therapy for people with schizophrenia spectrum disorders.

Methods

This randomised controlled trial was conducted with 134 outpatients with schizophrenia spectrum disorders; 67 of them received a six-session adherence therapy (in addition to usual care) and 67 received usual psychiatric care alone. Participants’ outcome measures included symptom severity, medication adherence, hospitalisation rates, insight into illness/treatment, and functioning.

Results

The adherence therapy group reported significantly greater improvements in symptom severity (p < 0.003), insight into illness/treatment (p < 0.001), functioning (p < 0.005), duration of re-hospitalisations (p < 0.005), and medication adherence (p < 0.005) over 18 months follow-up, when compared with usual care alone.

Conclusions

Motivational-interviewing-based adherence therapy can be an effective approach to treatment for people with early stage of schizophrenia who poorly adhere to medication regimen.

Trial registration

ClinicalTrials.gov NCT01780116, registration date January 29, 2013.
Literature
1.
National Institute for Health and Clinical Excellence. Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Update). London: NICE; 2009.
2.
Chien WT, Yip ALK. Current approaches to treatments for schizophrenia spectrum disorders, Part I: an overview and medical treatments. Neuropsychiatr Dis Treat. 2013;9:1311–32.PubMedCentralCrossRefPubMed
3.
4.
5.
6.
Dawn V, Weiden P, Sajatovic M, Scott J, Carpenter D, Ross R, et al. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from expert consensus guidelines. J Psychiatr Pract. 2010;16:306–24.CrossRef
7.
Gray R, White J, Schultz M, Abderhalden C. Enhancing medication adherence in people with schizophrenia: an international programme of research. Int J Ment Health Nurs. 2010;19:36–44.CrossRefPubMed
8.
Maneesakorn S, Robson D, Gournay K, Gray R. An RCT of adherence therapy for people with schizophrenia in Chiang Mai. Thailand J Clin Nurs. 2007;16:1302–12.CrossRefPubMed
9.
Schultz M, Gray R, Spiekermann A, Abderhalden C, Behrens J, Driessen M. Adherence therapy following an acute episode of schizophrenia: a multi-centre randomised controlled trial. Schizophr Res. 2013;146:59–63.CrossRef
10.
Staring AB, van der Gaag M, Koopmans GT, Selten JP, van Bevern JM, Hengeveld MW, et al. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br J Psychiatry. 2010;197:448–55.CrossRefPubMed
11.
Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M. Insight into psychosis and quality of life. Compr Psychiatry. 2006;47:265–9.CrossRefPubMed
12.
Bora E, Tucel M, Pantelis C. Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res. 2009;109:1–9.CrossRefPubMed
13.
14.
Rüsch N, Corrigan PW. Motivating interviewing to improve insight and treatment adherence in schizophrenia. Psychiatr Rehab J. 2002;26:23–32.CrossRef
15.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth text revised edition (DSM-IV-TR). Washington: APA; 2000.CrossRef
16.
17.
Stevens J. Applied Multivariate Statistics for the Social Sciences. 4th ed. New Jersey: Mahwah; 2002.
18.
Schultz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–32.CrossRef
19.
Bezchlibnyk-Butler KZ, Jeffries JJ, Virani AS. Clinical Handbook of Psychotropic Drugs. 17th ed. Boston: Hogrefe and Huber; 2007.
20.
Coldman EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286–90.CrossRef
21.
Bell M, Milstein R, Beam-Goulet J, Lysaker P, Cicchetti D. The positive and negative syndrome scale and brief psychiatric rating scale: reliability, comparability, and predictive validity. J Nerv Ment Dis. 1992;180:723–8.CrossRefPubMed
22.
McEvoy JP, Apperson LG, Applebaum PS, Ortlip P, Brecosky J, Hammill K, et al. Insight in schizophrenia: its relation to acute psychopathology. J Nerv Ment Dis. 1989;177:43–7.CrossRefPubMed
23.
Chien WT, Thompson DR. Effects of a mindfulness-based psychoeducation programme for Chinese patients with schizophrenia: two-year follow-up. Br J Psychiatry. 2014;205:52–9.CrossRefPubMed
24.
Schneider LC, Struening EL. SLOF: a behavioural rating scale for assessing the mentally ill. Soc Work Res Abstr. 1983;19:9–21.CrossRefPubMed
25.
Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry. 1998;172:413–9.CrossRefPubMed
26.
Tabachnick BG, Fidell LS. Using Multivariate Statistics. 6th ed. London: Prentice Hall; 2012.
27.
Müller R, Büttner O. A critical discussion of intraclass correlation coefficients. Stat Med. 1994;13:2465–76.CrossRefPubMed
28.
Levensky ER, Forcehimes A, O’Donohue WT, Beltz K. Motivational Interviewing: an evidence-based approach to counseling helps patients follow treatment recommendations. Am J Nurs. 2007;107:50–8.CrossRefPubMed
29.
Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, et al. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand. 2000;102:203–10.CrossRefPubMed
30.
O’Donnell M, Donohoe G, Sharkey L, Owens N, Migone M, Harries R, et al. Compliance therapy: a randomized controlled trial in schizophrenia. BMJ. 2003;327:834.PubMedCentralCrossRefPubMed
31.
Gray R, Leese M, Bindman J, Becker T, Burti L, David A, et al. Adherence therapy for people with schizophrenia: European multicentre randomized controlled trial. Br J Psychiatry. 2006;189:508–14.CrossRefPubMed
32.
Naber D, Karow A, Lambert M. Subjective well-being under neuroleptic treatment and its relevance or compliance. Acta Psychiatr Scand. 2005;111:29–34.CrossRef
33.
Quené H, van den Bergh H. On multilevel modelling of data from repeated measures designs: a tutorial. Speech Comm. 2004;43:103–21.CrossRef
Metadata
Title
Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial
Authors
Wai Tong Chien
Jolene Mui
Richard Gray
Eric Cheung
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0744-6

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue

Debate

Palliative psychiatry for severe persistent mental illness as a new approach to psychiatry? Definition, scope, benefits, and risks

Research article

Influence of premorbid BMI on clinical characteristics at presentation of adolescent girls with eating disorders

Research article

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

Study protocol

A randomized trial to identify accurate and cost-effective fidelity measurement methods for cognitive-behavioral therapy: project FACTS study protocol

Research article

Schizophrenia-spectrum patients treated with long-acting injectable risperidone in real-life clinical settings: functional recovery in remitted versus stable, non-remitted patients (the EVeREST prospective observational cohort study)

Research article

Association between abnormal default mode network activity and suicidality in depressed adolescents